C

Corcept Therapeutics

develops cortisol-modulating therapies for Cushing's syndrome

Associate Director of Biostatistics

Quantitative Biology & BiostatisticsConfirmed live in the last 24 hours
Full-timeRedwood City, CA, USA$183.5k - $269.8k

About the Job

Requirements

  • Knowledge of global regulatory guidance on statistical methods for analyses of clinical data, and global submission requirements.
  • Proficiency with statistical programming in SAS.
  • Familiarity with SAS/GRAPH, SAS/MACRO, and R.
  • Demonstrated ability to apply complex statistical methods and conduct and interpret the results.
  • 5+ years of experience in clinical trial development.
  • Demonstrated ability for project management of projects in clinical development.
  • Experience managing delivery of statistical projects by CROs.
  • Applicants must be currently authorized to work in the United States on a full-time basis.

Responsibilities

  • Lead the execution of statistical components of Corcept Development programs.
  • Manage external statisticians and statistical programmers.
  • Partner with Clinical Development, Regulatory, Manufacturing, and Commercial organizations on the design and execution of clinical trials in the Corcept portfolio.
  • Oversee execution of the statistical components of clinical studies by CROs and independent contractors, and manage on-time and quality delivery of CRO-generated analysis results.
  • Partner with Statistical Programming to generate statistical analyses for internal and external presentations, and validate statistical analysis results generated by CROs.
  • Partner with Statistical Programming to evaluate CDISC electronic data packages for completeness, regulatory standards compliance, and submission readiness.
  • Stay current with regulatory requirements for statistical methods of analyses and scientific developments in statistical methods for clinical trials.
  • Consult the internal audit team in assessing CRO regulatory compliance with respect to statistical SOPs.
  • Participate in standards governance and development of Corcept Biostatistical SOPs.

Desired Qualifications

  • Doctorate in Statistics, Biostatistics, or Mathematics.

About the Company

Corcept Therapeutics

develops cortisol-modulating therapies for Cushing's syndrome

Corcept Therapeutics develops and commercializes cortisol modulators to treat disorders caused by abnormal cortisol levels. Its core product, Korlym (mifepristone), blocks cortisol’s action by acting as a cortisol receptor antagonist and is approved for hypercortisolism in Cushing’s syndrome. The company differentiates itself with a dedicated focus on cortisol modulation, an extensive pipeline of proprietary molecules, and ongoing development beyond Korlym. Its goal is to improve outcomes for patients with cortisol-related disorders by expanding access to effective therapies and advancing new treatments.

Company size
501-1,000
Company stage
IPO
Headquarters
Menlo Park, CA
Founded
1998

Recently Posted Jobs

Explore more opportunities at Corcept Therapeutics

See more jobs